Subscribe
8 September 2025NewsCareersMuireann Bolger

Former PTAB judge joins Sterne Kessler

Appointment is the third ex-PTAB staffer to join, strengthens the firm’s position as a “PTAB powerhouse”.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
Barnes & Thornburg reveals five new IP leaders
8 September 2025   The US firm has ramped up its business growth strategy with the new hires, who will represent different IP practice and industry areas.
Careers
Alston & Bird partner with strong Japanese ties jumps to new firm
25 August 2025   Bilingual litigator brings experience of handling IP disputes across multiple industries, from medical devices and pharmaceuticals to consumer electronics and apparel.
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025   Wilson Sonsini, Desmarais, and Wolf Greenfield were among the winners at the inaugural LSPN Awards USA 2025 in Boston, which celebrated excellence in life sciences IP across 20 categories.


Editor's picks

A second bite at the Apple: Adjudicating redesigns after an ITC exclusion order
Americas
A second bite at the Apple: Adjudicating redesigns after an ITC exclusion order
23 October 2025

Editor's picks

Americas
A second bite at the Apple: Adjudicating redesigns after an ITC exclusion order
23 October 2025
Americas
Top pharma, biotech, and medtech experts gather at LSPN Fall
21 October 2025
Big Pharma
Moderna TM counsel: Commoditising work using AI is a ‘moral obligation’
16 October 2025
Americas
‘Death knell’ for investment: Universities warn against Lutnick’s royalty sharing proposal
13 October 2025
Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025
Americas
Global vaccine patents rise, as data reveals shift in Big Pharma strategy
1 October 2025

More features

A second bite at the Apple: Adjudicating redesigns after an ITC exclusion order
Less is more: patent lawyers flip the script after Amgen
‘Doing more with less’: In-house counsel on budgets and strategy
End of the ‘Death Squad’? Squires puts PTAB on trial
Data and delivery: Inside AI's inventorship dilemma
Weil continues expansion with top trade secrets litigator
Top pharma, biotech, and medtech experts gather at LSPN Fall
Mitsubishi Tanabe doubles down on Radicava protection